Open Access<p>Doxorubicin and Edelfosine Combo-Loaded Lipid–Polymer Hybrid Nanoparticles for Synergistic Anticancer Effect Against Drug-Resistant Osteosarcoma</p>
Author(s) -
Ping Yang,
Lian Zhang,
Tian Wang,
Qi Liu,
Jing Wang,
Yaling Wang,
Zhiquan Tu,
Feng Lin
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s259428
Subject(s) - nanocarriers , doxorubicin , osteosarcoma , pharmacology , apoptosis , in vivo , chemistry , mtt assay , cancer cell , in vitro , cancer research , drug , chemotherapy , cancer , medicine , biochemistry , biology , microbiology and biotechnology
The failure of chemotherapy in osteosarcoma results in drug resistance and acute side effects in the body.